Paulo Rodriguez

24PUBLICATIONS
206CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical mycologyBiologically active moleculesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Sep 11, 2026
KRAS-G12C inhibition-induced enrichment of MHC-Ihigh immune-active tumor cells directs immune-effector TME development to augment therapeutic efficacy.

|Jun 02, 2026
Sphingosine kinase-2 inhibition promotes immunogenic differentiation of myeloid-derived suppressor cells through an Acetyl-CoA carboxylase-phosphatidylcholine axis.

|Jan 20, 2026
Medium-Chain Fatty Acid Receptor GPR84 Modulates Cytotoxic CD8 T-cell Antitumor Immunity through Metabolic Reprogramming.

Phaethon Philbrook, Matthew J Dean, Maria Dulfary Sanchez-Pino

|Dec 12, 2025
TAp73 mediates anti-tumor immunity through regulation of lipid metabolism in the lung tumor microenvironment.

Hayley D Ackerman, Vanessa Y Rubio, Andrew J Davis

|Nov 13, 2025
Multicellular immune ecotypes within solid tumors predict real-world therapeutic benefits with immune checkpoint inhibitors.

Xuefeng Wang, Tingyi Li, Islam Eljilany

|Sep 24, 2025
Engineering synthetic agonists for targeted activation of Notch signaling.

David H Perez, Daniel Antfolk, Shiun Chang

Pageof 4

Frequent Collaborators

6 joint publications

Jose R Conejo-Garcia

6 joint publications

Xuefeng Wang

5 joint publications

John M Koomen

4 joint publications

Xiaoqing Yu